A comparison of cis-platinum-Vindesine and cis-platinum-Etoposide combined with radiotherapy for previously untreated localized inoperable non-small cell lung cancer
- 1 July 1989
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 25 (7) , 1039-1043
- https://doi.org/10.1016/0277-5379(89)90385-4
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Vindesine, cisplatin, and bleomycin combination chemotherapy in non-small cell lung cancer: survival and quality of lifeEuropean Journal of Cancer and Clinical Oncology, 1986
- Cis-platinum and vindesine in combination in the treatment of non-small cell lung cancerEuropean Journal of Cancer and Clinical Oncology, 1985
- Cisplatin, vindesine and bleomycin (CVB) combination chemotherapy of advanced non-small cell lung cancerCancer, 1983
- A review of etoposide in patients with non-small-cell lung cancer (NSCLC)Cancer Treatment Reviews, 1982
- Etoposide and cis-platinum in non-small-cell bronchogenic carcinomaCancer Treatment Reviews, 1982
- Etoposide alone and in combination with cyclophosphamide, adriamycin and cis-platinum in patients with MO and MI non-small-cell lung cancerCancer Treatment Reviews, 1982
- Combined radiotherapy and chemotherapy with cyclophosphamide, adriamycin, methotrexate, procarbazine (camp) in 64 consecutive patients with epidermoid bronchogenic carcinoma, limited disease: A prospective studyInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Patterns of failure in patients with inoperable carcinoma of the lungCancer, 1981
- Vindesine in the treatment of small cell and non-small cell bronchogenic carcinoma: preliminary resultsCancer Treatment Reviews, 1980
- A clinical trial of the oral form of 4′-demethyl-epipodophyllotoxin-β-D ethylidene glucoside (NSC 141540) VP 16–213Cancer, 1975